Array Patch Ltd is leveraging its proprietary, award winning DerMapTM dissolving microneedle patch technology to develop new treatments across a number of therapeutic areas which are more efficacious and safer.

Array Patch Ltd is leveraging its proprietary, award winning DerMapTM dissolving microneedle patch technology to develop new treatments across a number of therapeutic areas which are more efficacious and safer.

Technological • Pre-clinical proof of concept for ITZ-DerMapTM. • Publications (peer review) concerning DerMapTM technology. & Team • Assembled team with over 75 years of industry experience relevant to the business of ArrayPatch. • Assembled panel of international advisors. • Identified CDMOs and CROs to support development. Intellectual Property • DerMapTM patent advanced to nationalization phase (WO2020250210A1). Awards/Recognition • ‘Innovation of the Year’ - Pharma Industry Awards 2022. • ‘Commercial Activity of the Year’ - SSPC 2022. • ‘Ireland’s Top 100 Hospital and Healthcare Achievers - HPN Professional 2022. • 1st prize at the "1st Start-up Retreat" Porto, Portugal 2022. • Winner of 2023 IDEATE Ireland competition. • Finalist of Enterprise Ireland Show Case 2024. Funding • Horizon 2020/EI grant €0.3M (UCC). • Proof of Concept Commercialisation Fund 2020 grant from EI €0.3M (UCC). • Commercialisation-Fund grant from EI 2022 €0.74M (UCC).